← Back to Search

CBD for Anxiety

Phase 2
Waitlist Available
Research Sponsored by Mclean Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial will evaluate the effect of CBD oil on anxiety in adults. Participants will use CBD oil twice daily for six weeks, in addition to their normal treatment, and will be assessed weekly.

Eligible Conditions
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Self-Reported Anxiety as Assessed by the Beck Anxiety Inventory (BAI)

Side effects data

From 2014 Phase 2 trial • 50 Patients • NCT01844687
2%
headache
2%
Blurred Vision
2%
Cold Symptoms
2%
Gastrointestinal Upset
2%
anxiety
100%
80%
60%
40%
20%
0%
Study treatment Arm
Active MJ With 0 mg CBD
Active MJ With 200 mg CBD
Active MJ With 400 mg CBD
Active MJ With 800 mg CBD
Inactive MJ With 0 mg CBD
Inactive MJ With 200 mg CBD
Inactive MJ With 400 mg CBD
Inactive MJ With 800 mg CBD

Trial Design

1Treatment groups
Experimental Treatment
Group I: CBDExperimental Treatment1 Intervention
0.5ml of sublingual CBD solution (30mg/ml) administered twice daily for six weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabidiol
FDA approved

Find a Location

Who is running the clinical trial?

Mclean HospitalLead Sponsor
212 Previous Clinical Trials
21,582 Total Patients Enrolled
6 Trials studying Anxiety
469 Patients Enrolled for Anxiety

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How has the safety of cannabidiol (CBD) been evaluated?

"CBD has not been proven to be efficacious yet, thus it was assigned a safety score of 2. Nevertheless, there is some evidence that suggests its safe usage in clinical trials."

Answered by AI

How many participants has this clinical trial accepted thus far?

"Absolutely, the records available on clinicaltrials.gov verify that recruitment is currently underway for this trial. This research project was initially published on February 1st 2021 and lastly updated April 8th 2021; 52 patients need to be sourced from just one medical facility."

Answered by AI

Are there any available slots left for participation in this medical trial?

"According to the data hosted on clinicaltrials.gov, this medical trial is actively seeking out potential candidates. The initial posting date was February 1st 2021 and it has been modified as recently as April 8th 2021."

Answered by AI

Are there any additional research projects that have studied the effects of cannabidiol?

"Currently, there are 79 clinical trials dedicated to researching the effects of CBD. 16 of these studies are at Phase 3 and 289 trial sites exist across the world, with a majority based in Ribeirao Preto, Sao Paulo."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
Massachusetts
How old are they?
18 - 65
What site did they apply to?
McLean Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I’m hoping this study helps my condition.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. McLean Hospital: < 24 hours
Average response time
  • < 1 Day
~3 spots leftby Apr 2025